Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial - Wunderink, R G; Matsunaga, Y; Ariyasu, M (Lancet Infect Dis, 2021)